Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
Authors
- Hoon Kang (ORCID: https://orcid.org/0000-0002-9822-4760)
- Ohsang Kwon (ORCID: https://orcid.org/0000-0003-0464-5124)
- Subin Lee (ORCID: https://orcid.org/0009-0000-9557-7774)
- Yang Won Lee (ORCID: https://orcid.org/0000-0003-1268-1248)
- Moon‐Bum Kim (ORCID: https://orcid.org/0000-0003-4837-0214)
- Bark‐Lynn Lew (ORCID: https://orcid.org/0000-0003-4443-4161)
- Chang‐Hun Huh (ORCID: https://orcid.org/0000-0003-3944-7777)
- Sangseok Kim (ORCID: https://orcid.org/0000-0001-9717-9710)
- Gwang Seong Choi (ORCID: https://orcid.org/0000-0002-5766-0179)
- Jung Eun Kim (ORCID: https://orcid.org/0000-0003-1670-0995)
- Young Lee (ORCID: https://orcid.org/0000-0001-9205-1785)
- Do Young Kim (ORCID: https://orcid.org/0000-0002-0194-9854)
- Jin Park (ORCID: https://orcid.org/0000-0002-8830-5479)
- Ju Young Kim
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Seoul National University Hospital (KR)
- Seoul National University Bundang Hospital (KR)
- Hanall Biopharma (South Korea) (KR)
- Konkuk University Medical Center (KR)
- St. Mary's Hospital (US)
- Pusan National University Hospital (KR)
- Jeonbuk National University Hospital (KR)
- Chungnam National University Hospital (KR)
- Kangdong Sacred Heart Hospital (KR)
- Kyung Hee University Hospital at Gangdong (KR)
- Inha University Hospital (KR)
- Jeonbuk National University (KR)
Publication Details
- Journal
- Annals of Dermatology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5021/ad.25.048
- Citations
- 1
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.84
Funders
- Handok
- Yuhan
- Daewoong Pharmaceutical Company